IDYA

NASDAQ HEALTHCARE

Ideaya Biosciences Inc

$37.59

$0.14 (+0.37%)

Live quote

52w: $24.24 – $42.68

Loading chart…

P/E Ratio—

P/B Ratio3.01

EV/EBITDA—

Debt/Equity—

ROE-9.48%

ROIC—

Revenue Growth3024.43%

Gross Margin—

IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality, is focused on the discovery and development of targeted therapies for selected patient populations using molecular diagnostics. The company is headquartered in South San Francisco, California.

Own IDYA? Track it here.

Create a free account to add IDYA to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account